JPRN-UMIN000050897尚未招募Unknown
Observational study to assess treatment patterns and clinical outcome in advance and/or recurrent endometrial cancer after adjuvant chemotherapy - PEACH study
JGOG0 个研究点目标入组 400 人开始时间: 2023年5月10日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 400
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1) Patients deemed inappropriate as study subjects by the principal investigator and co-investigators 2) Patients who underwent radiation therapy or chemoradiotherapy after surgery (including external radiation therapy and brachytherapy, but palliative radiation therapy for pain relief to bones, brain, or other sites is allowed) 3) Patients who received preoperative treatment 4) Patients who underwent drug therapy with regimens other than cohorts A-C 5) Patients with concomitant active multiple cancers 6) Patients who are participating in clinical research involving interventions (including clinical trials) at the time of case registration.
研究者
相似试验
招募中
不适用
POMEesophageal cancerJPRN-jRCT1040220010Kei Muro1,000
尚未招募
不适用
Study to evaluate treatment responses to inhaled corticosteroids and to observe cough symptom for a long time period in patients diagnosed with cough variant asthma or eosinophilic bronchitis who is complaining of coughKCT0005679Asan Medical Center120
已完成
4 期
An observational study investigating the treatment satisfaction of atopic dermatitis patients who have switched to ointment (W/O emulsion) formulation of Very Strong Class topical corticosteroidsatopic dermatitisJPRN-UMIN000019873Mie University Hospital60
已完成
不适用
Prospective observational study on treatment strategy for pancreatic cancer focusing on the chemotherapy responsePancreatic cancerJPRN-UMIN000042331Department of hepato-biliary-pancreatic surgery, Okayama University Graduate School of Medicine76
已完成
不适用
Observational study to collect data on treatment progression in women treated for bladder weakness (overactive bladder with or without incontinence) with GRANU FINK® feminabladder weakness (overactive bladder with or without incontinence)DRKS00009945Omega Pharma Innovation & Development NV123